Bioalmanac
Klowverine
KLOW-verine · Klowverine blend · double KLOW
KLOW with the three repair peptides doubled: 50 mg GHK-Cu with 20 mg each of BPC-157, TB-500 and KPV. The least documented of the named blends.
Storage
- Freeze-dried powder
- Refrigerated at 2–8 °C, protected from light.
- After mixing
- Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
- Long-term, frozen
- Unopened powder is stable at −20 °C or colder.
Reconstitution — 110 mg vial, 2200 mcg dose
On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.
| Water added | Concentration | Volume to draw | Units | Doses per vial |
|---|---|---|---|---|
| 1 mL | 110 mg/mL | 0.02 mL | 2 units | 50 |
| 2 mL | 55 mg/mL | 0.04 mL | 4 units | 50 |
| 3 mL | 36.667 mg/mL | 0.06 mL | 6 units | 50 |
| 5 mL | 22 mg/mL | 0.1 mL | 10 units | 50 |
Dose ranges reported in sources
Descriptions of what sources report, not recommendations.
| Goal | Range | Frequency | Source |
|---|---|---|---|
| Commonly described community protocol | 2200–4400 mcg | Daily, in courses of 4 to 8 weeks | Community practice |
When to stop
- Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
- An injection site that becomes hot, spreading or produces pus.
- Any new or changing lump. Several components are associated with proliferation in animal models.
Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.